Search for: "Sepracor, Inc."
Results 1 - 20
of 46
Sort by Relevance
|
Sort by Date
21 Oct 2011, 7:40 am
., a subsidiary of Mylan Inc. [read post]
16 Sep 2011, 5:00 am
SEC Charges Former Consulting Executive and Friend with Insider Trading Ahead of Biotech Takeovers The SEC alleges that Scott Allen learned confidential information in advance of the acquisitions of Millennium Pharmaceuticals Inc. and Sepracor Inc. through his work at a global consulting firm that was advising the acquiring Japanese companies as they made cash tender offers. [read post]
13 Dec 2010, 11:45 am
©2010 Amaxx Risk Solutions, Inc. [read post]
6 Oct 2010, 11:43 pm
Sepracor Inc., concerning Dey’s ANDAs for generic versions of Sepracor’s XOPENEX (levalbuterol HCl) – the U.S. [read post]
7 Sep 2010, 6:10 pm
Genpharm Inc. et al. [read post]
18 Aug 2010, 12:19 am
Eon Labs, Inc. [read post]
2 Aug 2010, 8:05 am
Sepracor Inc. v. [read post]
26 Jul 2010, 8:03 am
Lunesta, the prescription sleep aid is made by Sepracor, Inc.; and buried in its Medication Guide, it says "Lunesta is not for children. [read post]
16 Jun 2010, 3:02 pm
Sandoz, Inc. [read post]
10 Feb 2010, 4:47 pm
Sepracor Inc (EPLAW) Zyvox (Linezolid) – US: Patent infringement complaint filed following a Paragraph IV certification: Pfizer Inc. et al. v. [read post]
14 Jan 2010, 11:09 am
” Glaxo, Inc. v. [read post]
2 Nov 2009, 5:34 pm
Department of Labor announced a $3,319,718 grant to assist about 600 laid off workers at nine Massachusetts companies with training and employment services.Impacted workers , who lost their jobs between November 2008 and October 2009, are from ACT Electronics Inc., Altus Pharmaceuticals Inc., Bose Corp., DHL, EMC Corp., Sepracor Inc., Snap-on Inc., Staples Inc. and Taylor Corp., in information, manufacturing, retail and transportation… [read post]
27 Oct 2009, 1:40 pm
" He then focuses on the the fact the FDA-approved label for a prescription medication often comes up short as regards the drug's efficacy, or benefits: In the case of Sepracor Inc.'s blockbuster sleeping pill Lunesta, it's virtually impossible to tell how well the drug works based on the labeling, which only indicates that it worked better than placebo, or a dummy pill. [read post]
6 Jul 2009, 4:37 pm
In re Sepracor Inc. [read post]
1 Jul 2009, 7:14 am
(Patent Docs) Products Avapro (Irbesartan) – Spain: Fourth Commercial Court of Barcelona rejects preliminary injunction petition by Sanofi-Aventis and Bristol-Myers Squibb for alleged patent infringement (International Law Office) Cozaar/Hyzaar (Losartan/Hydrochlorothiazide and Losartan) –US: Teva sues FDA over generic Cozaar and Hyzaar 180-day exclusivity forfeiture and patent delisting rule (The FDA Law Blog) Eloxatin (Oxaliplatin) – US: District Court of New Jersey… [read post]
23 Jun 2009, 9:46 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Eloxatin (Oxaliplatin) – US: District Court New Jersey grants summary judgment of non-infringement in favour of Hospira, Teva and others concerning patent relating to Sanofi’s Eloxatin: Sanofi-Aventis v Sandoz (SmartBrief) (The IP Factor) (GenericsWeb) (Patents4Life) General Europe’s ever changing landscape Pirate Party,… [read post]
22 Jun 2009, 8:57 pm
Sepracor Inc. et al. v. [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) India: Public sector IP and socially responsible licensing (Spicy IP) India: Pharma lobby wants a probe into delayed orders (Spicy IP) UK: Euro costs in UK litigation: Actavis UK Ltd v Novartis AG (PatLit) US: Two biosimilars bills introduced in the House: HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act; and H.R. 1548, the Pathway to BioSimilars Act (California Biotech Law Blog) (Managing… [read post]
16 Mar 2009, 8:52 pm
By Suresh Pillai -- Sepracor Settles Xopenex Suit With Barr Last week, Sepracor Inc. and Barr Pharmaceuticals, Inc. [read post]
20 Feb 2009, 1:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: GSK floats patent pool for neglected diseases (Spicy IP) (Intellectual Property Watch) (IAM) (guardian.co.uk) (IPKat) European Patent Office accepts traditional knowledge database from Indian government to help stop ‘biopiracy’ (Managing Intellectual Property) (Out-Law) (Intellectual Property Watch) General GSK… [read post]
